Pediatric Pulmonology

Article	Citations
Clinical and CT features in pediatric patients with COVID‐19 infection: Different points from adults	659
Clinical characteristics of COVID‐19 in children: A systematic review	190
Clinical manifestations of children with COVID‐19: A systematic review	184
COVID‐19 and multisystem inflammatory syndrome in children: A systematic review and meta‐analysis	115
Pediatric long‐COVID: An overlooked phenomenon?	106
Asthma and COVID‐19 in children: A systematic review and call for data	80
During the COVID‐19 pandemic where has respiratory syncytial virus gone?	80
Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype	79
Novel coronavirus infection in children outside of Wuhan, China	69
Effect of the COVID‐19 pandemic on anxiety among children with cystic fibrosis and their mothers	69
Impact of COVID‐19 social distancing on viral infection in France: A delayed outbreak of RSV	60
Combining bacteriophages with cefiderocol and meropenem/vaborbactam to treat a pan‐drug resistant Achromobacter species infection in a pediatric cystic fibrosis patient	60
Is vitamin D deficiency a risk factor for COVID‐19 in children?	58
Lung ultrasound in the neonatal intensive care unit: Review of the literature and future perspectives	57
COVID‐19 in childhood: Transmission, clinical presentation, complications and risk factors	57
Clinical characteristics of a case series of children with coronavirus disease 2019	55
Insight into COVID‐2019 for pediatricians	52
Influenza and respiratory syncytial virus during the COVID‐19 pandemic: Time for a new paradigm?	51
Efficacy of noninvasive respiratory support modes for primary respiratory support in preterm neonates with respiratory distress syndrome: Systematic review and network meta‐analysis	47
What we know so far about Coronavirus Disease 2019 in children: A meta‐analysis of 551 laboratory‐confirmed cases	45
Effects of the COVID‐19 lockdown on sleep duration in children and adolescents: A survey across different continents	41
The association between secondhand smoke and childhood asthma: A systematic review and meta‐analysis	41
Efficacy of noninvasive respiratory support modes as postextubation respiratory support in preterm neonates: A systematic review and network meta‐analysis	41
Impact of COVID‐19 outbreak in acute bronchiolitis: Lesson from a tertiary Italian Emergency Department	40
Increasing life expectancy in cystic fibrosis: Advances and challenges	38

Pediatric asthma and COVID‐19: The known, the unknown, and the controversial	38
Psychiatric and general health effects of COVID‐19 pandemic on children with chronic lung disease and parents' coping styles	37
Unexpected decline in pediatric asthma morbidity during the coronavirus pandemic	37
Neurodevelopmental outcomes of infants with bronchopulmonary dysplasia	36
Insight into the pediatric and adult dichotomy of COVID‐19: Age‐related differences in the immune response to SARS‐CoV‐2 infection	36
Lessons unfolding from pediatric cases of COVID‐19 disease caused by SARS‐CoV‐2 infection	35
Pediatric lung imaging features of COVID‐19: A systematic review and meta‐analysis	35
Nusinersen for spinal muscular atrophy type 1: Real‐world respiratory experience	33
Persistent recovery of pancreatic function in patients with cystic fibrosis after ivacaftor	33
Protracted respiratory findings in children post‐SARS‐CoV‐2 infection	33
Integration of mental health screening and treatment into cystic fibrosis clinics: Evaluation of initial implementation in 84 programs across the United States	32
Pediatric asthma control during the COVID‐19 pandemic: A systematic review and meta‐analysis	32
Overview of gene therapy in spinal muscular atrophy and Duchenne muscular dystrophy	31
Bacteriophage therapy for infections in CF	31
Review of CFTR modulators 2020	31
Psychological interventions during COVID pandemic: Telehealth for individuals with cystic fibrosis and caregivers	31
Persistent pulmonary hypertension of the newborn	30
Lung growth and pulmonary function after prematurity and bronchopulmonary dysplasia	30
Care recommendations for the respiratory complications of esophageal atresia‐tracheoesophageal fistula	29
Reduction of pulmonary exacerbations in young children with cystic fibrosis during the COVID‐19 pandemic	29
Structural and functional development in airways throughout childhood: Children are not small adults	29
Telemedicine in children with medical complexity on home ventilation during the COVID‐19 pandemic	28
Pediatric P‐ANCA vasculitis following COVID‐19	27
Value of lung ultrasonography to predict weaning success in ventilated neonates	27
Seroprevalence of anti‐SARS‐CoV‐2 IgG antibodies in children with household exposure to adults with COVID‐19: Preliminary findings	27
Reduced pediatric urgent asthma utilization and exacerbations during the COVID‐19 pandemic	27
Assessment of respiratory muscles and motor function in children with SMA treated by nusinersen	26
Aerosol transmission of SARS‐CoV‐2 by children and adults during the COVID‐19 pandemic	26
Readmission drivers for children with medical complexity: Home nursing shortages cause health crises	25
High flow nasal cannula treatment for obstructive sleep apnea in infants and young children	24
Lung ultrasound in the diagnosis and monitoring of 30 children with coronavirus disease 2019	24
Oxidant and antioxidant balance in patients with COVID‐19	24
COVID‐19 under 19: A meta‐analysis	24
Trend of sweat chloride values in a cohort of patients carrying CFTR mutations of varying clinical consequence: Is there a risk of increasing sweat chloride over time?	24
The isolation period should be longer: Lesson from a child infected with SARS‐CoV‐2 in Chongqing, China	24
Pulmonary hypertension in the child with bronchopulmonary dysplasia	23
Practical guide for pediatric pulmonologists on imaging management of pediatric patients with COVID‐19	23
Prevalence of exercise‐induced bronchoconstriction and laryngeal obstruction in adolescent athletes	23
Technical validity and usability of a novel smartphone‐connected spirometry device for pediatric patients with asthma and cystic fibrosis	22
Age and environmental exposures influence the fecal bacteriome of young children with cystic fibrosis	22
Reproducibility and reference values of diaphragmatic shortening fraction for term and premature infants	22
Effects of the COVID‐19 pandemic and lockdown on symptom control in preschool children with recurrent wheezing	22
Impaired lung function following e‐cigarette or vaping product use associated lung injury in the first cohort of hospitalized adolescents	22
Impact of elexacaftor–tezacaftor–ivacaftor on bacterial colonization and inflammatory responses in cystic fibrosis	22
Lung ultrasound in bronchiolitis	21
Exposure to violence, chronic stress, nasal DNA methylation, and atopic asthma in children	21
Pulmonary function sequelae after respiratory syncytial virus lower respiratory tract infection in children: A systematic review	21
Risk factors for atopic diseases and recurrent respiratory tract infections in children	21
Effect of a combined exercise program on physical fitness, lung function, and quality of life in patients with controlled asthma and exercise symptoms: A randomized controlled trial	21
Assessment of sidestream end‐tidal capnography in ventilated infants on the neonatal unit	20

Lung ultrasound predicts histological lung injury in a neonatal model of acute respiratory distress syndrome	20
Lung ultrasound for early surfactant treatment: Development and validation of a predictive model	20
Maternal asthma, breastfeeding, and respiratory outcomes in the first year of life	20
COVID‐19 infection in a paucisymptomatic infant: Raising the index of suspicion in epidemic settings	20
The prevalence of lower airway anomalies in children with Down syndrome compared to controls	20
Life with pediatric home ventilation: Expectations versus experience	20
A narrative review of diaphragmatic ultrasound in pediatric critical care	20
Managing a tertiary‐level NICU in the time of COVID‐19: Lessons learned from a high‐risk zone	20
Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS	20
Predictors of proper inhaler technique and asthma control in pediatric patients with asthma	19
Clinical characteristics of acute respiratory syndrome with SARS‐CoV‐2 infection in children in South China	19
Rescue of respiratory failure in pulmonary alveolar proteinosis due to pathogenic MARS1 variants	19
Morbidity and respiratory outcomes in infants requiring tracheostomy for severe bronchopulmonary dysplasia	19
Reliability of machine learning to diagnose pediatric obstructive sleep apnea: Systematic review and meta‐analysis	19
Immune‐related factors associated with pneumonia in 127 children with coronavirus disease 2019 in Wuhan	19
A worldwide charter for all children with asthma	19
Ten key points about COVID‐19 in children: The shadows on the wall	18
Ultrasound assessment of diaphragmatic function in type 1 spinal muscular atrophy	18
Nasal mask vs binasal prongs for nasal continuous positive airway pressure in preterm infants: A systematic review and meta‐analysis	18
Vitamin‐D supplementation as an adjunct to standard treatment of asthma in children: A randomized controlled trial (ViDASTA Trial)	18
Multiple breath washout quality control in the clinical setting	18
The effect of the COVID‐19 lockdown on children with asthma‐related symptoms: A tertiary care center experience	17
Case series: Adolescent victims of the vaping public health crisis with pulmonary complications	17
Obesity‐related asthma in children: A role for vitamin D	17
Prediction of extubation readiness using lung ultrasound in preterm infants	17
Children and COVID‐19: Microbiological and immunological insights	17
The use of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis postliver transplant: A case series	16
Respiratory outcomes of “new” bronchopulmonary dysplasia in adolescents: A multicenter study	16
Long‐term pulmonary function testing in pediatric bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation	16
Real‐time effects of COVID‐19 pandemic lockdown on pediatric respiratory patients	16
Comparison of delivered distending pressures in the oropharynx in preterm infant on bubble CPAP and on three different nasal interfaces	16
Coronavirus global pandemic: An overview of current findings among pediatric patients	16
Frequency of asthma exacerbation in children during the coronavirus disease pandemic with strict mitigative countermeasures	16
Efficacy of fiberoptic bronchoscopy and bronchoalveolar lavage in childhood‐onset, complicated plastic bronchitis	16
Characteristics of infants or children presenting to outpatient bronchopulmonary dysplasia clinics in the United States	16
Characterizing e‐cigarette vaping‐associated lung injury in the pediatric intensive care unit	16
Bronchopulmonary dysplasia as a determinant of respiratory outcomes in adult life	16
Pediatric obstructive sleep apnea—Dental professionals can play a crucial role	16
Respiratory rate is an early predictor of clinical deterioration in children	16
Outcomes of infants born during the first 9 years of CF newborn screening in the United States: A retrospective Cystic Fibrosis Foundation Patient Registry cohort study	15
Entering the era of highly effective modulator therapies	15
Decannulation following tracheostomy in children: A systematic review of decannulation protocols	15
Lung ultrasound score and diuretics in preterm infants born before 32 weeks: A pilot study	15
Delayed acute bronchiolitis in infants hospitalized for COVID‐19	15
The respiratory impact of novel therapies for spinal muscular atrophy	15
Novel imaging techniques for cystic fibrosis lung disease	15
Home nursing for children with home mechanical ventilation in the United States: Key informant perspectives	15
Diagnostic value of lung ultrasonography in children with COVID‐19	15
Long‐term pulmonary sequelae in adolescents post‐SARS‐CoV‐2 infection	15
SARS‐CoV‐2 acute bronchiolitis in hospitalized children: Neither frequent nor more severe	15
The association of area deprivation and state child health with respiratory outcomes of pediatric patients with cystic fibrosis in the United States	15
Secondary household transmission of SARS‐CoV‐2 among children and adolescents: Clinical and epidemiological aspects	15
Clinical characteristics of COVID‐19 in children: Are they similar to those of SARS?	15
High‐flow nasal cannula vs standard respiratory care in pediatric procedural sedation: A randomized controlled pilot trial	14
Physical activity in children and adolescents with cystic fibrosis: A systematic review and meta‐analysis	14
Restless sleep disorder, restless legs syndrome, and periodic limb movement disorder—Sleep in motion!	14
Efficacy and safety of EBUS‐TBNA and EUS‐B‐FNA in children: A systematic review and meta‐analysis	14
Can lung ultrasound score accurately predict surfactant replacement? A systematic review and meta‐analysis of diagnostic test studies	14
Improvements in frailty contribute to substantial improvements in quality of life after lung transplantation in patients with cystic fibrosis	14
Diaphragmatic atrophy and dysfunction in critically ill mechanically ventilated children	14
Early nasal continuous positive airway pressure failure prediction in preterm infants less than 32 weeks gestational age suffering from respiratory distress syndrome	14
Comparison of chest radiography and chest CT for evaluation of pediatric COVID‐19 pneumonia: Does CT add diagnostic value?	14
CFTR modulator drug desensitization: Preserving the hope of long term improvement	14
Cardiac autonomic modulation assessed by heart rate variability in children with asthma	14
High flow nasal cannula versus standard low flow nasal oxygen during flexible bronchoscopy in children: A randomized controlled trial	14
Azithromycin for preventing bronchopulmonary dysplasia in preterm infants: A systematic review and meta‐analysis	14
Healthcare utilization and costs of pediatric home mechanical ventilation in Canada	13
Depression and anxiety in mothers of home ventilated children before and during COVID‐19 pandemic	13
Pulmonary pneumatoceles in neonates	13
SARS‐CoV‐2 and Streptococcus pneumoniae coinfection as a cause of severe pneumonia in an infant	13
Agreement between spirometry and impulse oscillometry for lung function assessment in 6‐year‐old children born extremely preterm and at term	13
Bacterial colonization dynamics associated with respiratory syncytial virus during early childhood	13
Comparison of a handheld turbine spirometer to conventional spirometry in children with cystic fibrosis	13
Area deprivation and respiratory morbidities in children with bronchopulmonary dysplasia	13
Pierre Robin and breathing: What to do and when?	13
Bronchoscopy in children with COVID‐19: A case series	13
Sleep‐disordered breathing and markers of morbidity in children and adolescents with cystic fibrosis	13
The importance of anti‐vaping vigilance—EVALI in seven adolescent pediatric patients in Northeast Ohio	13
Vaping associated lung injury: A potentially life‐threatening epidemic in US youth	13
Oscillometry—A reasonable option to monitor lung functions in the era of COVID‐19 pandemic	13

Elexacaftor–Tezacaftor–Ivacaftor improves exercise capacity in adolescents with cystic fibrosis	13
Parent perspectives on facilitating decision‐making around pediatric home ventilation	12
Associations of Helicobacter pylori seropositivity and gastric inflammation with pediatric asthma	12
Cytokine profile in Egyptian children and adolescents with COVID‐19 pneumonia: A multicenter study	12
Impact of nonpharmacological COVID‐19 interventions in hospitalizations for childhood pneumonia in Brazil	12
Effectiveness of hypertonic saline nebulization in airway clearance in children with non‐cystic fibrosis bronchiectasis: A randomized control trial	12
Nutrition and growth in infants with established bronchopulmonary dysplasia	12
Chylothorax in the neonate—A stepwise approach algorithm	12
Greater length of stay and hospital charges for severe asthma in children with depression or anxiety	12
Residential instability, neighborhood deprivation, and pediatric asthma outcomes	12
Overview of the ChILD Research Network: A roadmap for progress and success in defining rare diseases	12
Thoracoscopy versus thoracotomy for congenital lung malformations treatment: A single center experience	12
Respiratory syncytial virus and SARS‐CoV‐2 coinfections in children	12
Sustained recovery of exocrine pancreatic function in a teenager with cystic fibrosis treated with ivacaftor	12
Clinical features and accompanying findings of Pseudo‐Bartter Syndrome in cystic fibrosis	12
Predicting asthma exacerbation by impulse oscillometry evaluation of small airway function and fractional exhaled nitric oxide in preschool children	12
Effectiveness of fractional exhaled nitric oxide for asthma management in children: A systematic review and meta‐analysis	12
Delayed season's onset and reduction of incidence of bronchiolitis during COVID‐19 pandemic	12
Risk factors for redetectable positivity in recovered COVID‐19 children	12
Tracheal anomalies associated with Down syndrome: A systematic review	12
Risk factors for nontuberculous mycobacterial isolation in patients with cystic fibrosis: A meta‐analysis	12
Liberation and mortality outcomes in pediatric long‐term ventilation: A qualitative systematic review	12
Patient and family perspectives regarding the use of telehealth for cystic fibrosis care	12
Reference values for respiratory sinusoidal oscillometry in children aged 3 to 17 years	12
Impact of pharmacy technicians as part of an integrated health‐system pharmacy team on improvement of medication access in the care of cystic fibrosis patients	12
A survey: Understanding the health and perspectives of people with CF not benefiting from CFTR modulators	12
Tracheostomy trends in preterm infants with bronchopulmonary dysplasia in the United States: 2008–2017	12
Digital auscultation in PERCH: Associations with chest radiography and pneumonia mortality in children	12
Detection of bacterial pathogens using home oropharyngeal swab collection in children with cystic fibrosis	12
The return of RSV during the COVID‐19 pandemic	12
A proposal for the addressing the needs of the pediatric pulmonary work force	11
Skin wipe test: A simple, inexpensive, and fast approach in the diagnosis of cystic fibrosis	11
Incidence of nephrotoxicity with prolonged aminoglycoside exposure in patients with cystic fibrosis	11
Sildenafil for pulmonary hypertension in neonates: An updated systematic review and meta‐analysis	11
Extracellular vesicles influence the pulmonary arterial extracellular matrix in congenital diaphragmatic hernia	11
The cost‐utility of intravenous magnesium sulfate for treating asthma exacerbations in children	11
Persistent tachypnea of infancy: Follow up at school age	11
A child with SARS‐CoV2‐induced croup	11
Molecular characterization of Streptococcus pneumoniae isolated from pediatric patients in Shanghai, China	11
A systematic review of the clinical and genetic characteristics of Chinese patients with cystic fibrosis	11
Patients with cystic fibrosis and advanced lung disease benefit from lumacaftor/ivacaftor treatment	11
Cardiopulmonary phenotypic variability and discordance in Duchenne muscular dystrophy: Implications for new therapies	11
Impact of elexacaftor/tezacaftor/ivacaftor on vitamin D absorption in cystic fibrosis patients	11
Lung function and exercise capacity in prematurely born young people	11
Clinical, functional, and computed tomography findings in a cohort of patients with neuroendocrine cell hyperplasia of infancy	11
Lung clearance index: A new measure of late lung complications of cancer therapy in children	11
RSV through the COVID‐19 pandemic: Burden, shifting epidemiology, and implications for the future	11
Pulmonary manifestations of immune dysregulation in CTLA‐4 haploinsufficiency and LRBA deficiency	11
Understanding the environmental factors related to the decrease in Pediatric Emergency Department referrals for acute asthma during the SARS‐CoV‐2 pandemic	11
Beyond transplant: Roles of atrial septostomy and Potts shunt in pediatric pulmonary hypertension	11
Effect of breastfeeding duration on lung function, respiratory symptoms and allergic diseases in school‐age children	11
Detection of disease‐causing CFTR variants in state newborn screening programs	11
Epidemiologic Study of Cystic Fibrosis: 25 years of observational research	11
Maternal iron status during early pregnancy and school‐age, lung function, asthma, and allergy: The Generation R Study	11
Management of neuropsychiatric symptoms in adults treated with elexacaftor/tezacaftor/ivacaftor	11
Outcomes of early repeat sweat testing in infants with cystic fibrosis transmembrane conductance regulator‐related metabolic syndrome/CF screen‐positive, inconclusive diagnosis	11
Accuracy of lung and diaphragm ultrasound in predicting successful extubation in extremely preterm infants: A prospective observational study	11
Laboratory parameters between multisystem inflammatory syndrome in children and Kawasaki disease	11
The effectiveness of a mobile high‐frequency chest wall oscillation (HFCWO) device for airway clearance	11
Central airway issues in bronchopulmonary dysplasia	11
Sleep disordered breathing: Assessment and therapy in the age of emerging neuromuscular therapies	10
Rethinking furosemide use for infants with bronchopulmonary dysplasia	10
COVID‐19: Impact, experiences, and support needs of children and young adults with cystic fibrosis and parents	10
Evaluation of the novel coronavirus disease in Turkish children: Preliminary outcomes	10
Assessment of early lung disease in young children with CF: A comparison between pressure‐controlled and free‐breathing chest computed tomography	10
COVID‐19 in a child with tuberculous airway compression	10
Ground glass and fibrotic change in children with surfactant protein C dysfunction mutations	10
Cardiorespiratory effects of NIV‐NAVA, NIPPV, and NCPAP shortly after extubation in extremely preterm infants: A randomized crossover trial	10
Use of saliva sample to detect C‐reactive protein in children with pneumonia	10
Lung ultrasound evaluation of incremental PEEP recruitment maneuver in children undergoing cardiac surgery	10
Ultrasound of pneumothorax in neonates: Diagnostic value of the anterior transverse plane and of mirrored ribs	10
Clinical change 2 years from start of elexacaftor‐tezacaftor‐ivacaftor in severe cystic fibrosis	10
Do pulmonary and extrapulmonary features differ among cystic fibrosis, primary ciliary dyskinesia, and healthy children?	10
Incidence, predictors of success and outcome of LISA in very preterm infants	10
Transcutaneous monitoring of diaphragm activity as a measure of work of breathing in preterm infants	10
Diagnosis, management, and outcomes of pediatric tracheostomy‐associated infections: A scoping review	10
Life course body mass index through childhood and young adulthood and risks of asthma and pulmonary function impairment	10
Chronic wet cough in Australian children: Societal costs and quality of life	10
Newer bronchopulmonary dysplasia definitions and prediction of health economics impacts in very preterm infants	10
The ISPAT project: Implementation of a standardized training program for caregivers of children with tracheostomy	10
The association of vitamin D and vitamin E levels at birth with bronchopulmonary dysplasia in preterm infants	10
Exercise testing for children with cystic fibrosis: A systematic review	10
Heme oxygenase‐1 alleviates eosinophilic inflammation by inhibiting STAT3‐SOCS3 signaling	10
Co‐morbid anxiety and depression in childhood asthma and its effect on symptom control: A cross sectional study	10
Thymidine‐auxotrophic Staphylococcus aureus small‐colony variant bacteremia in a patient with cystic fibrosis	10
Phenotypic variance in pediatric obstructive sleep apnea	10
Lung ultrasound scoring in invasive mechanically ventilated children with severe bronchiolitis	10
Risk factors for recurrent pulmonary exacerbation in idiopathic pulmonary hemosiderosis	10
Respiratory syncytial virus seropositivity at birth is associated with adverse neonatal respiratory outcomes	10
Cobalamin C deficiency presenting with diffuse alveolar hemorrhage and pulmonary microangiopathy	10
Pseudo‐Bartter syndrome in Chinese children with cystic fibrosis: Clinical features and genotypic findings	10
Autophagy‐related 5 gene mRNA expression and ATG5 rs510432 polymorphism in children with bronchial asthma	10
Vascular and pulmonary comorbidities in children with congenital EA/TEF	10
Metered‐dose inhalers versus nebulization for the delivery of albuterol for acute exacerbations of wheezing or asthma in children: A systematic review with meta‐analysis	10
Cerebral and splanchnic oxygenation during automated control of inspired oxygen (FiO2) in preterm infants	10